Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 30, 2026
TickeronGET DAILY SIGNALS
FXG vs KXI: Weighing a Factor-Driven U.S. Staples ETF Against a Global Cap-Weighted Alternative

FXG vs KXI: Weighing a Factor-Driven U.S. Staples ETF Against a Global Cap-Weighted Alternative

Key Takeaways

  • FXG is a U.S.-only, smart-beta consumer staples fund that uses a multi-factor "AlphaDEX" methodology, while KXI is a broad, market-cap-weighted global consumer staples portfolio.
  • KXI holds roughly 100+ names across developed and emerging markets; FXG is far more concentrated at roughly 40 holdings with a notable mid-cap tilt.
  • Cost structure favors KXI, which carries an expense ratio near 0.38%, versus approximately 0.63% for FXG.
  • Risk and diversification profiles diverge sharply: KXI is anchored by mega-cap staples leaders, while FXG leans on food, ingredients, and distribution names with higher single-stock sensitivity.
  • Tickeron AI Verdict: KXI — lower cost, broader diversification, larger liquidity, and more consistent recent sector momentum give the global fund the structural edge.

Why These Two Staples ETFs Deserve a Closer Look

Consumer staples ETFs are often viewed as sources of defensive, relatively stable equity exposure, yet two funds in the same sector can behave quite differently in practice. FXG and KXI highlight this distinction clearly. FXG applies a U.S.-focused, factor-driven approach to the staples space, whereas KXI offers a global, market-cap-weighted benchmark. They are not interchangeable products; instead, each provides a distinct way to gain durable, income-oriented consumer exposure, with notable differences in geographic scope, portfolio construction, and costs. I also checked this using Tickeron’s AI Screener to see how the two compare within the broader industry context.

A Closer Look at First Trust Consumer Staples AlphaDEX Fund (FXG)

FXG tracks the StrataQuant Consumer Staples Index, which relies on the AlphaDEX selection process. Rather than weighting by market size, the index evaluates U.S. staples stocks from the Russell 1000 universe through a combination of growth and value factors, then gives larger allocations to higher-ranked holdings. The fund follows a rules-based, passively managed strategy and undergoes quarterly reconstitution and rebalancing.

The portfolio typically contains about 40 to 42 securities, resulting in greater concentration than many staples peers. Largest positions have included Cardinal Health (CAH), Freshpet (FRPT), Post Holdings (POST), Pilgrim's Pride (PPC), and McCormick (MKC), along with names such as Ingredion, Smithfield Foods, Seaboard, and Constellation Brands. The factor tilt produces an atypical sector mix where staples remain dominant but healthcare distribution and select industrial or food-processing businesses also appear. Its expense ratio stands at approximately 0.63%, above that of many low-cost cap-weighted staples funds, consistent with the enhanced-index approach.

A Closer Look at iShares Global Consumer Staples ETF (KXI)

KXI is a passive, market-cap-weighted fund tracking the S&P Global 1200 Consumer Staples Sector Capped Index, a global benchmark of staples equities. It generally holds about 100 to 112 securities across developed markets with a smaller emerging-markets allocation, featuring a U.S. weighting near 60% and additional exposure to the United Kingdom, Japan, Switzerland, France, and Canada.

Top holdings center on multinational staples leaders such as Walmart (WMT), Costco (COST), Procter & Gamble (PG), Coca-Cola (KO), Philip Morris International (PM), PepsiCo (PEP), and Altria (MO), together with non-U.S. names including Nestlé, Unilever, and British American Tobacco. The expense ratio is approximately 0.38%, with semi-annual income distributions. Assets exceed $1 billion and average daily volume is higher, providing greater liquidity than FXG.

Current Industry and Thematic Context

Both funds operate within the consumer staples sector, which investors have traditionally favored for resilient earnings and reliable cash flows amid slower growth or higher volatility. Recent cycles have brought several cross-currents into focus. Steady inflation and shifts toward value-oriented spending have benefited discount retailers and private-label brands, while input costs and freight pressures have weighed on food producers and distributors. Currency movements affect KXI more due to its international exposure, whereas FXG is more sensitive to domestic U.S. food and agriculture trends. Tobacco and beverage holdings, which carry greater weight in KXI, continue to face regulatory and health-related pressures, while FXG’s emphasis on food-related names makes it more responsive to commodity costs and animal-protein pricing.

Performance and Positioning Insights

Over recent periods and market cycles, KXI has generally produced stronger and steadier returns than FXG, aided by the strength of mega-cap retailers and global staples leaders as well as lower cost drag. FXG’s factor-tilted, mid-cap-oriented construction has led to more variable relative results, with its food, ingredient, and distribution holdings showing greater idiosyncratic volatility. Both funds maintain betas well below the broader market, reflecting their defensive character, yet FXG’s narrower holdings and smaller-cap bias have often resulted in larger drawdowns and wider tracking differences relative to the sector. For investors evaluating positioning, KXI provides more consistent, benchmark-style exposure, while FXG serves as a more concentrated, alpha-oriented satellite holding.

Tickeron AI Verdict

From the structural factors I observe, Tickeron’s AI currently points toward KXI over FXG. KXI combines a meaningfully lower expense ratio, substantially wider geographic and single-stock diversification, stronger liquidity, and more consistent recent momentum driven by large-cap staples leadership. FXG remains a valid factor-based, U.S.-centric choice for those seeking a concentrated, alpha-oriented tilt, yet its higher costs and narrower, mid-cap-skewed portfolio introduce comparatively greater relative risk. On a probability-weighted view of cost efficiency, diversification, liquidity, and trend consistency, KXI holds the structural advantage in this comparison.

Using Tickeron’s AI Screener for ETF Research

In my own work, I often rely on Tickeron’s AI Screener to quickly filter sector ETFs by technical patterns, fundamentals, and performance metrics. The tool surfaces relevant holdings and comparisons efficiently, helping refine ideas without manual screening. It has become a regular part of evaluating options like these two funds before reaching conclusions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FXG, KXI

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


FXG sees MACD Histogram crosses below signal line

FXG saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In 38 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FXG as a result. In 73 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

FXG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.

Following a +1.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 259 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

The Aroon Indicator entered an Uptrend today. In 176 of 272 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.

Notable companies

The most notable companies in this group are Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), PepsiCo (NASDAQ:PEP), Altria Group (NYSE:MO), McKesson Corp (NYSE:MCK), CVS HEALTH Corp (NYSE:CVS), Mondelez International (NASDAQ:MDLZ), Kroger Co (The) (NYSE:KR), Archer Daniels Midland Company (NYSE:ADM), Constellation Brands (NYSE:STZ).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant® Consumer Staples Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the consumer staples sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.

Market Cap

The average market capitalization across the First Trust Consumer Staples AlphaDEX Fund (FXG) ETF is 51.47B. The market cap for tickers in the group ranges from 3.09B to 411.62B. KO holds the highest valuation in this group at 411.62B. The lowest valued company is FRPT at 3.09B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust Consumer Staples AlphaDEX Fund (FXG) ETF was -3%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was 2%. TSN experienced the highest price growth at 11%, while BG experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the First Trust Consumer Staples AlphaDEX Fund (FXG) ETF was 22%. For the same stocks of the ETF, the average monthly volume growth was 57% and the average quarterly volume growth was 49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 48
Price Growth Rating: 47
SMR Rating: 59
Profit Risk Rating: 69
Seasonality Score: 10 (-100 ... +100)
Paper Trades 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.